Palladon (Hydromorphone Hydrochloride)

Hydromorphone hydrochloride is an opioid that acts on the central nervous system to relieve pain. It is commonly prescribed for:

• Acute postoperative pain: Provides rapid relief following surgical procedures.
• Cancer‑related pain: Helps control persistent pain associated with malignant disease.
• Severe chronic non‑cancer pain: Used when other analgesics are insufficient.
• Palliative care pain: Improves comfort in end‑of‑life settings.

• Hydromorphone binds with high affinity to µ‑opioid receptors in the brain and spinal cord, inhibiting the release of excitatory neurotransmitters and reducing neuronal excitability. This receptor activation decreases the perception of pain and alters the emotional response to painful stimuli, producing analgesia.

Hydromorphone may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects

• Nausea: Feeling of queasiness or urge to vomit.
• Constipation: Reduced bowel movements and hard stools.
• Drowsiness: Increased sleepiness or fatigue.
• Dry mouth: Reduced salivation leading to a parched feeling.
• Itching: Mild skin pruritus.
• Lightheadedness: Transient dizziness or feeling faint.

Serious or Rare Side Effects

• Respiratory depression: Slowed or shallow breathing that can be fatal.
• Severe hypotension: Markedly low blood pressure.
• Opioid dependence or addiction: Development of physical or psychological reliance.
• Seizures: Uncontrolled electrical activity in the brain.
• Anaphylaxis: Acute allergic reaction with airway compromise.
• Adrenal insufficiency: Inadequate production of adrenal hormones.

When prescribing Hydromorphone, clinicians should consider several safety measures:

• Assess pain severity: Confirm that opioid therapy is appropriate for the level of pain.
• Review medical history: Identify respiratory disorders, head injury, or substance‑use disorder.
• Monitor for sedation: Observe patients for excessive drowsiness or impaired cognition.
• Adjust for renal/hepatic impairment: Dose may need modification in organ dysfunction.
• Educate on constipation management: Recommend laxatives or stool softeners.
• Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Hydromorphone can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• CNS depressants: Concurrent use with benzodiazepines or barbiturates can cause profound respiratory depression.
• MAO inhibitors: May precipitate severe hypertension or serotonin syndrome.
• Potent CYP3A4 inhibitors: Can increase hydromorphone plasma levels, raising overdose risk.

Moderate Interactions (Monitor Closely)

• Anticholinergic agents: May worsen constipation.
• Diuretics: Can enhance hypotensive effects.
• Serotonergic drugs: May increase risk of serotonin syndrome.
• Alcohol: Augments central nervous system depression.
• QT‑prolonging agents: May contribute to cardiac rhythm disturbances.